Literature DB >> 23690560

Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantification of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique.

Salil Srivastava1, Alessio Alfieri, Richard C M Siow, Giovanni E Mann, Paul A Fraser.   

Abstract

Activation of the redox-sensitive transcription factor NF-E2 related factor 2 (Nrf2) affords protection against cerebral ischaemia-reperfusion injury via the upregulation of antioxidant defence genes. We have quantified for the first time Nrf2 content in brains from rats subjected to stroke and from cultured bEnd.3 brain endothelial cells using a novel immunohistochemical technique. Male Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 70 min followed by reperfusion for 4, 24 or 72 h. Coronal brain sections were incubated with anti-Nrf2 primary and biotinylated-horseradish peroxidase-conjugated secondary antibody, after which sections were reacted with 3,3-diaminobenzidine (DAB) in the presence of hydrogen peroxide. The initial rates of DAB polymer formation were directly proportional to the Nrf2 protein concentration. Image processing was used to determine the temporal and spatial distribution of Nrf2 in nuclear and cytoplasmic compartments in stroke-affected and contralateral hemispheres. Nuclear to cytoplasmic Nrf2 ratios were increased in the stroke region after 24 h reperfusion and declined after 72 h reperfusion. Pretreatment with the Nrf2 inducer sulforaphane reduced total cellular Nrf2 levels in peri-infarct and core regions of the stroke hemisphere after 24 h reperfusion. Treatment of cultured murine brain endothelial cells with sulforaphane (2.5 μm) increased nuclear accumulation of Nrf2 over 1-4 h. We report the first quantitative measurements of spatial and temporal nuclear Nrf2 expression in rat brains following stroke, and show that sulforaphane pretreatment affects Nrf2 distribution in the brain of naïve rats and animals subjected to cerebral ischaemia. Our findings provide novel insights for targeting endogenous redox-sensitive antioxidant pathways to ameliorate the damaging consequences of stroke.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690560      PMCID: PMC3731611          DOI: 10.1113/jphysiol.2013.257964

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  62 in total

1.  Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes.

Authors:  Hao Pan; Handong Wang; Lin Zhu; Lei Mao; Liang Qiao; Xingfen Su
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

2.  Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software.

Authors:  Svend Kirkeby; Carsten Eckhart Thomsen
Journal:  J Immunol Methods       Date:  2005-06       Impact factor: 2.303

3.  Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.

Authors:  Tae Gen Son; Simonetta Camandola; Thiruma V Arumugam; Roy G Cutler; Richard S Telljohann; Mohamed R Mughal; Tyson A Moore; Weiming Luo; Qian-Sheng Yu; Delinda A Johnson; Jeffrey A Johnson; Nigel H Greig; Mark P Mattson
Journal:  J Neurochem       Date:  2009-12-17       Impact factor: 5.372

4.  High performance liquid chromatographic determination of acetoacetate by post-column derivatization with p-nitrobenzene diazonium fluoroborate.

Authors:  Susumu Yamato; Kiyomi Kobayashi; Keiko Ebara; Kenji Shimada; Shin Ohta
Journal:  Biol Pharm Bull       Date:  2003-04       Impact factor: 2.233

5.  Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

Authors:  E Heiss; C Herhaus; K Klimo; H Bartsch; C Gerhäuser
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

6.  p-Hydroxybenzyl alcohol prevents brain injury and behavioral impairment by activating Nrf2, PDI, and neurotrophic factor genes in a rat model of brain ischemia.

Authors:  Kyung-Yoon Kam; Seong Jin Yu; Nahee Jeong; Jeong Hwa Hong; Angela M A Anthony Jalin; Sungja Lee; Yong Won Choi; Chae Kwan Lee; Sung Goo Kang
Journal:  Mol Cells       Date:  2011-01-06       Impact factor: 5.034

7.  Stroke research at a crossroad: asking the brain for directions.

Authors:  Costantino Iadecola; Josef Anrather
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

8.  Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.

Authors:  Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

9.  Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.

Authors:  Agnieszka Jazwa; Ana I Rojo; Nadia G Innamorato; Marlen Hesse; Javier Fernández-Ruiz; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2011-03-28       Impact factor: 8.401

10.  Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: roles for F-actin and GPR30.

Authors:  David J Rowlands; Sarah Chapple; Richard C M Siow; Giovanni E Mann
Journal:  Hypertension       Date:  2011-02-07       Impact factor: 10.190

View more
  16 in total

Review 1.  Mechanisms of neurovascular dysfunction in acute ischemic brain.

Authors:  Y Terasaki; Y Liu; K Hayakawa; L D Pham; E H Lo; X Ji; K Arai
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

2.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

Review 3.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

Review 4.  Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models.

Authors:  Nilendra Singh; Megha Agrawal; Sylvain Doré
Journal:  ACS Chem Neurosci       Date:  2013-06-24       Impact factor: 4.418

5.  Comparisons of ethanol extracts of chinese propolis (poplar type) and poplar gums based on the antioxidant activities and molecular mechanism.

Authors:  Jianglin Zhang; Xueping Cao; Shun Ping; Kai Wang; Jinhu Shi; Cuiping Zhang; Huoqing Zheng; Fuliang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

6.  KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.

Authors:  Cinzia Antognelli; Eliana Trapani; Simona Delle Monache; Andrea Perrelli; Martina Daga; Stefania Pizzimenti; Giuseppina Barrera; Paola Cassoni; Adriano Angelucci; Lorenza Trabalzini; Vincenzo Nicola Talesa; Luca Goitre; Saverio Francesco Retta
Journal:  Free Radic Biol Med       Date:  2017-11-21       Impact factor: 7.376

7.  t-BHQ Protects Against Oxidative Damage and Maintains the Antioxidant Response in Malnourished Rats.

Authors:  Graciela Gavia-García; María de Los Ángeles Rosas-Trejo; Eduardo García-Mendoza; Rafael Toledo-Pérez; Mina Königsberg; Oralia Nájera-Medina; Armando Luna-López; María Cristina González-Torres
Journal:  Dose Response       Date:  2018-09-25       Impact factor: 2.658

Review 8.  Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential.

Authors:  Ardalan Zolnourian; Ian Galea; Diederik Bulters
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

Review 9.  Sulforaphane as a potential protective phytochemical against neurodegenerative diseases.

Authors:  Andrea Tarozzi; Cristina Angeloni; Marco Malaguti; Fabiana Morroni; Silvana Hrelia; Patrizia Hrelia
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

10.  NRF2 as a Therapeutic Target in Neurodegenerative Diseases.

Authors:  Mikah S Brandes; Nora E Gray
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.